Franzmann, E. J., Reategui, E. P., Pereira, L. H. M., Pedroso, F., Joseph, D., Allen, G. O., Hamilton, K., Reis, I., Duncan, R., Goodwin, W. J., Hu, J. J. and Lokeshwar, V. B. (2011), Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma. Head & Neck. doi: 10.1002/hed.21810

Cheung MC, Franzmann E, Sola JE, Pincus DJ, Koniaris LG. A Comprehensive Analysis of Parotid and Salivary Gland Cancer: Worse Outcomes for Male Gender. J Surg Res. February 2010

Germani RM, Civantos FJ, Elgart G, Roberts B, Franzmann EJ. Molecular Markers of Micrometastasis in Oral Cavity Carcinomas. Otolaryngol Head Neck Surg 141:52-8, 2009.

Goodwin WJ, Thomas GR, Parker DF, Joseph D, Levis S, Franzmann E, Anello C, Hu JJ. Unequal Burden of Head and Neck Cancer in the United States. Head Neck 30:358-71, 2008.

Sargi ZB, Franzmann EJ. Elective Neck Dissection in Early-Stage Oral Squamous Cell Carcinoma. Head Neck 30:273-4, 2008.

Elizabeth J. Franzmann, Erika P. Reategui, Felipe Pedroso, et al. Soluble CD44 Is a Potential Marker for the Early Detection of Head and Neck Cancer. Cancer Epidemiol Biomarkers Prev July 2007; 16:1348-1355.

Reategui EP, Antúnez de Mayolo AA, Das PM, Astor FC, Singal R, Hamilton KL, Goodwin WJ, Carraway KL, Franzmann EJ. Characterization of CD44v3-Containing Isoforms in Head and Neck Cancer. Cancer Biol Ther 2006;5:1163-8.

Elizabeth J. Franzmann, Erika P. Reategui, Kermit L. Carraway, et al. Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer. Cancer Epidemiol Biomarkers Prev March 2005; 14:735-739.

Franzmann, E. J., Schroeder, G.L., Goodwin, et al. (2003), Expression of Tumor Markers Hyaluronic Acid and Hyaluronidase (HYAL1) in Head and Neck Tumors. International Journal of Cancer, 106:438-445.

Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon LYW. A Novel CD44v3 Isoform is Involved in Head and Neck Squamous Cell Carcinoma Progression. Otolaryngol Head Neck Surg 2001; 24:426-32.